Novartis
Novartis is a global pharmaceutical company that researches, develops, manufactures, and markets innovative prescription medicines across therapeutic areas such as oncology, immunology, cardiovascular, and neuroscience. It serves patients worldwide through branded drugs and generics, selling primarily to healthcare providers, hospitals, pharmacies, and governments. The company generates revenue from the commercialization of patented therapies, licensing, and related healthcare products and services.
- Revenue
- $1B+
- Employees
- 5,001+
- Founded
- 1996
- Headquarters
- Basel, Switzerland
Novartis customers on Arbolus
Customers who reviewed Novartis
Seniority of Novartis customers
Most people who reviewed Novartis hold C-Suite roles (74%), followed by Director (26%).
- C-Suite 74%
- Director 26%
Customers sample
Employer names and spend open once the report publishes.
What 22 Arbolus experts think of Novartis
Overall sentiment: Positive
NPS distribution skews highly positive, with 60% of respondents providing scores of 9 or 10. Only 2 outliers provided an NPS of 1. Renewal intent is strong among high-NPS and high-spend participants, with all those indicating future spend planning to renew. More than 70% report being in place for over a year, reflecting deep operational integration. Key themes are sustained satisfaction, broad stickiness, and positive impact matched to original decision-making needs.
Tell us when the Novartis report publishes.
We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.
Sentiment
36 Net Promoter Score, from 22 scored reviews- Promoters 11
- Passives 8
- Detractors 3
Written answers and themes publish with the full report.
Renewal intent
Plan to renew 58%Plan to renew, by seniority
- 67% 9 answers
- 0% 2 answers
- 100% 1 answer
- 9.1/10 Average score from customers who will renew
- 5.7/10 Average score from undecided customers
- 6.5/10 Average score from customers not renewing
For people who use Novartis
Do you use Novartis at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 22 customers of Novartis have already contributed
Takes a few minutes. Your identity stays anonymous.